Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Clinical Pharmacokinetics|October 29, 2004
Effect of colesevelam HCl on single-dose fenofibrate pharmacokineticsMichael R Jones, Brian A Baker, Philip MathewReproductive Toxicology (Elmsford, N.Y.)|September 27, 2005
Colesevelam hydrochloride does not cause maternal or fetal toxicity in rats and rabbitsJudith K Marquis, Rafif Dagher, Brian A Baker, et al.American Heart Journal|April 30, 2013
Thienopyridine efficacy and cigarette smoking statusKevin P Bliden, Brian A Baker, Thomas D Nolin, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 9, 2017
The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS studyMark B Effron, Tracy Y Wang, Gregg C Fonarow, et al.Journal of the American College of Cardiology|August 9, 2008
The association of cigarette smoking with enhanced platelet inhibition by clopidogrelKevin P Bliden, Joseph Dichiara, Lookman Lawal, et al.Platelets|March 1, 2012
A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrelIsabell Bernlochner, Tanja Morath, Patricia B Brown, et al.Journal of the American College of Cardiology|June 16, 2012
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trialMatthew J Price, James S Walder, Brian A Baker, et al.JACC. Cardiovascular Interventions|January 1, 2016
Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS StudyLarry R Jackson, Christine Ju, Marjorie Zettler, et al.Journal of Cardiovascular Pharmacology|January 27, 2011
The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology dataBaojin Zhu, Mark B Effron, M Pandurang Kulkarni, et al.European Heart Journal|January 22, 2011
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialDominick J Angiolillo, Juan Jose Badimon, Jorge F Saucedo, et al.Pageof 3